Search

Search Results

• The Prognostic Value of the Galectin-1 Expression by Tumor Plasma Cells and the Concentration of Some Serum Cytokines (IL-2, IL-6, TNF) in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

  Zhanna Mikhailovna Kozich, V.N. Martinkov, D.A. Zinovkin, Zh.N. Pugacheva, N.N. Klimkovich

  65-72

  01.01.2025

• Comparative Efficacy of Autologous Hematopoietic Stem Cell Mobilization Regimens in Multiple Myeloma Patients

  Ivan Ivanovich Kostroma, Zh.V. Chubukina, V.A. Yudina, N.A. Romanenko, E.I. Stepchenkova, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  43-49

  17.05.2024

• Primary Immune Thrombocytopenia and Thrombopoietin Receptor Agonists: Feasibilities of Treatment Discontinuation upon Achieving Stable Complete Platelet Response

  O.Yu. Vinogradova, M.M. Pankrashkina, Anna Leonidovna Neverova, M.V. Chernikov, L.A. Mukha, D.I. Shikhbabaeva, V.V. Ptushkin

  413-425

  28.09.2023

• Follicular Lymphoma of Grades 1–3А With and Without t(14;18)(q32;q21): A Prognosis, Choice of Chemotherapy and Its Outcomes

  Ekaterina Sergeevna Nesterova, E.E. Zvonkov, A.M. Kovrigina, T.N. Obukhova, B.V. Biderman, A.B. Sudarikov, Ya.K. Mangasarova, A.U. Magomedova, A.K. Smolyaninova, S.M. Kulikov, E.N. Parovichnikova

  361-369

  28.09.2023

• Expression of the WNT Family Genes in Multiple Myeloma Patients with Different Chemotherapy Response

  Natella Iosifovna Enukashvili, L.A. Belik, I.I. Kostroma, N.Yu. Semenova, V.A. Balashova, D.V. Baram, S.V. Gritsaev, S.S. Bessmeltsev, S.V. Sidorkevich, I.S. Martynkevich

  294-302

  09.06.2023

• Quality of Life Changes in Patients with Chronic Immune Thrombocytopenia in the Process of Romiplostim Therapy, its Efficacy and Safety in the Real-World Setting: Results of a Multi-Center Observational Study

  T.I. Ionova, O.Yu. Vinogradova, T.V. Shelekhova, D.G. Sherstnev, A.V. Proidakov, E.V. Lyyurova, M.M. Pankrashkina, L.A. Mukha, E.E. Markova, N.V. Novitskaya, T.I. Pospelova, T.N. Babaeva, N.B. Bulieva, G.B. Kuchma, E.A. Andreevskaya, E.E. Zinina, M.V. Frolova, K.B. Trizna, I.L. Shestopalova, T.V. Shneider, S.A. Volkova, S.G. Zakharov, I.I. Mulina, I.E. Solov’eva, A.A. Myasnikov, A.A. Kuchin, L.B. Khvorostenko, N.M. Porfirieva, Tatyana Pavlovna Nikitina, V.V. Ptushkin, S.V. Gritsaev

  154-165

  03.03.2023

• The Prognostic Value of Immunophenotypic Characteristics of Plasma Cells in Newly Diagnosed Multiple Myeloma Patients Treated with First-Generation Proteasome Inhibitor Bortezomib

  Galina Nikolaevna Salogub, E.B. Rusanova, M.V. Gorchakova, E.A. Belyakova

  377-387

  01.10.2022

• Stratification of Patients with Multiple Myeloma: State-of-the-Art and Prospects

  Anna Yurevna Aksenova, A.S. Zhuk, E.I. Stepchenkova, S.V. Gritsaev

  259-270

  01.07.2022

• Current Quality-of-Life Aspects in Patients with Classical Ph-Negative Myeloproliferative Neoplasms in the Russian Federation: Results and Discussion of the National Observational Program MPN-QoL-2020

  T.I. Ionova, E.A. Andreevskaya, E.N. Babich, N.B. Bulieva, O.Yu. Vinogradova, E.M. Volodicheva, S.V. Voloshin, N.N. Glonina, S.K. Dubov, N.B. Esef’eva, A.Yu. Zaritskey, E.E. Zinina, M.O. Ivanova, T.Yu. Klitochenko, A.V. Kopylova, A.D. Kulagin, G.B. Kuchma, O.Yu. Li, E.G. Lomaia, A.L. Melikyan, V.Ya. Melnichenko, S.N. Menshakova, N.V. Minaeva, T.A. Mitina, E.V. Morozova, Tatyana Pavlovna Nikitina, O.E. Ochirova, A.S. Polyakov, T.I. Pospelova, A.V. Proidakov, O.A. Rukavitsyn, G.Sh. Safuanova, I.N. Subortseva, M.S. Fominykh, M.V. Frolova, T.V. Shelekhova, D.G. Sherstnev, T.V. Shneider, V.A. Shuvaev, Z.K. Abdulkhalikova, L.V. Anchukova, I.A. Apanaskevich, A.N. Arnautova, M.V. Barabanshchikova, N.V. Berlina, A.P. Bityukov, E.A. Gilyazitdinova, V.I. Gilmanshina, E.K. Egorova, E.V. Efremova, E.B. Zhalsanova, E.N. Kabanova, O.B. Kalashnikova, A.E. Kersilova, T.I. Kolosheinova, P.M. Kondratovskii, E.V. Koroleva, A.N. Kotelnikova, N.A. Lazareva, N.S. Lazorko, E.V. Lyyurova, A.S. Lyamkina, Yu.N. Maslova, E.S. Mileeva, N.E. Mochkin, E.K. Nekhai, Ya.A. Noskov, E.S. Osipova, M.M. Pankrashkina, E.V. Potanina, O.D. Rudenko, T.Yu. Rozhenkova, E.I. Sbityakova, N.T. Siordiya, A.V. Talko, E.I. Usacheva, Yu.B. Chernykh, T.V. Chitanava, K.S. Shashkina, D.I. Shikhbabaeva, K.S. Yurovskaya

  176-197

  01.04.2022

• Efficacy, Safety, and Tolerance of Gemtuzumab Ozogamicin Combined with FLAG/FLAG-Ida or Azacitidine in Relapsed/Refractory Acute Myeloblastic Leukemia

  Irina Garmaevna Budaeva, D.V. Zaitsev, A.A. Shatilova, E.N. Tochenaya, A.V. Petrov, R.I. Vabishchevich, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, S.V. Efremova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  299-307

  01.07.2021

• Value of PD-L1 Protein Expression in the Combined Prognostic Model of Diffuse Large B-Cell Lymphoma

  Svetlana Valerevna Samarina, N.Yu. Semenova, N.V. Minaeva, D.A. Dyakonov, V.A. Rosin, E.V. Vaneeva, S.V. Gritsaev

  308-314

  01.07.2021

• Polymorphism of Interleukins and Tumor Necrosis Factor α Genes in Multiple Myeloma Patients with Autologous Hematopoietic Stem Cell Transplantation

  Svetlana Pavlovna Svitina, Zh.Yu. Sidorova, I.I. Kostroma, A.A. Zhernyakova, A.V. Chechetkin, Zh.V. Chubukina, S.V. Gritsaev, S.I. Kapustin, S.S. Bessmeltsev

  340-346

  01.07.2021

• Retrospective Survival Analysis of Multiple Myeloma Patients after Autologous Hematopoietic Stem Cell Transplantation

  Ivan Ivanovich Kostroma, A.A. Zhernyakova, I.M. Zapreeva, Zh.Yu. Sidorova, N.Yu. Semenova, E.V. Karyagina, E.I. Stepchenkova, S.S. Bessmeltsev, A.V. Chechetkin, S.V. Gritsaev

  73-79

  01.01.2021

• Comparative Analysis of Myelofibrosis Treatment Outcomes with the Use of Ruxolitinib Versus Ruxolitinib with Subsequent Allogeneic Hematopoietic Stem Cell Transplantation

  Mariya Vladimirovna Barabanshchikova, E.V. Morozova, Yu.Yu. Vlasova, T.L. Gindina, A.V. Evdokimov, I.M. Barkhatov, V.V. Baikov, I.O. Ivanova, T.A. Rudakova, E.A. Bakin, I.S. Moiseev, A.D. Kulagin

  22-30

  01.01.2021

• Long-Term Outcomes of Nivolumab Therapy in Patients with Relapsed/Refractory Classic Hodgkin’s Lymphoma after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Real Clinical Practice

  Kirill Viktorovich Lepik, N.P. Volkov, N.B. Mikhailova, E.V. Kondakova, L.A. Tsvetkova, Yu.R. Zalyalov, E.E. Lepik, L.V. Fedorova, A.V. Beinarovich, M.V. Demchenkova, O.G. Smykova, P.V. Kotselyabina, I.S. Moiseev, V.V. Baikov, B.V. Afanasyev

  280-288

  01.07.2020

• Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome

  Nikolai Yur’evich Tsvetkov, E.V. Morozova, I.M. Barkhatov, I.S. Moiseev, M.V. Barabanshchikova, A.V. Tishkov, D.S. Bug, N.V. Petukhova, E.A. Izmailova, S.N. Bondarenko, B.V. Afanasyev

  170-175

  01.04.2020

• Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry

  Kamil Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian

  363-376

  01.10.2019

• Current Genetic Models for Prediction of Primary Myelofibrosis

  Lyubov Borisovna Polushkina, V.A. Shuvaev, M.S. Fominykh, Yu.A. Krivolapov, E.A. Belyakova, Z.P. Asaulenko, E.V. Motyko, L.S. Martynenko, M.P. Bakai, N.Yu. Tsybakova, S.V. Voloshin, S.S. Bessmeltsev, A.V. Chechetkin, I.S. Martynkevich

  391-397

  01.10.2019

• Clinical and Laboratory Characteristics and Differential Diagnosis between Secondary Hemophagocytic Syndrome and Sepsis

  Vsevolod Gennad’evich Potapenko, M.Yu. Pervakova, A.V. Titov, O.V. Goloshchapov, S.V. Lapin, E.A. Surkov, A.V. Klimovich, O.P. Mironova, N.N. Petrova, N.Yu. Chernookaya, E.V. Karyagina, N.V. Skorobogatova, E.S. Pavlyuchenko, E.A. Karev, N.A. Potikhonova, V.A. Dubkova, A.Yu. Kaskov, A.V. Rysev, T.G. Kulibaba, N.V. Medvedeva

  329-337

  01.07.2019

• Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

  Svetlana Valer’evna Samarina, E.L. Nazarova, N.V. Minaeva, E.N. Zotina, I.V. Paramonov, S.V. Gritsaev

  68-72

  01.01.2019

• First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, A.L. Shipaeva, I.V. Matveeva, M.N. Shirokova, A.C. Proskurina, N.A. Red’kina, E.G. Gemdzhyan

  150-159

  01.04.2018

• The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity

  Kamil’ Daniyalovich Kaplanov, T.Yu. Klitochenko, A.L. Shipaeva, M.N. Shirokova, I.V. Matveeva, N.B. Lavrishina

  358-365

  01.07.2017

• Effect of Patients’ Endocrine Status on Effectiveness of Treatment with Rituximab: State of the Art

  Yuliya Valer’evna Komoza, V.A. Komoza, S.V. Chernavskii, O.A. Rukavitsyn

  187-190

  01.04.2017

• Diagnostic and Prognostic Value of Biochemical Markers of Infectious Complications of High-Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation in Malignant Lymphoproliferative Diseases

  Vladislav Olegovich Sarzhevskii, Yu.N. Dubinina, V.Ya. Mel’nichenko

  113-119

  01.01.2017

• Rearrangement of 11q23 Chromosome Region in Acute Myeloid Leukemias in Children

  Elena Vol’fovna Fleishman, O.I. Sokova, A.V. Popa, G.A. Tsaur, L.N. Konstantinova, O.M. Plekhanova, M.V. Strigaleva, E.S. Nokhrina, V.S. Nemirovchenko, O.R. Arakaev

  446-455

  01.10.2016

• Quality of life in adolescent and young adult Hodgkin’s lymphoma survivors

  Ye.G. Arshanskaya, S.V. Semochkin, A.G. Rumyantsev

  184-191

  01.04.2014